United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2004_register
executive
2010-09-23
article
Prospective Grant of Exclusive License: 4′ and 4′,4″-substituted-3-α-(diphenylmethoxy) Tropane Analogs as Cocaine Therapeutics
Notices
D09002ee1bde4a93b
D09002ee1bde4a9d7
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
National Institutes of Health
originator
org
United States Government Agency or Subagency
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive license worldwide to practice the invention embodied in of U.S. Patent 5,792,775, issued on August 11, 1998, entitled, ``4' and 4',4''-substituted-3-[alpha]-(diphenylmethoxy) tropane analogs as cocaine therapeutics' to Phase2 Discovery, having a place of business in the state of Ohio. The field of use may be limited to the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The United States of America is the assignee of the patent rights in this invention. This announcement is the first notice to grant an exclusive license to this technology.
69 FR 75996
https://www.govinfo.gov/app/details/FR-2004-12-20/04-27781
04-27781
fr20de04-102
4140-01-P
https://www.govinfo.gov/app/details/FR-2004-12-20/04-27781
https://www.govinfo.gov/content/pkg/FR-2004-12-20/html/04-27781.htm
https://www.govinfo.gov/content/pkg/FR-2004-12-20/pdf/04-27781.pdf
1 p.
75996
75996
69 FR 75996
Prospective Grant of Exclusive License: 4′ and 4′,4″-substituted-3-α-(diphenylmethoxy) Tropane Analogs as Cocaine Therapeutics; Federal Register Vol. 69, Issue
NOTICE
04-27781
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
2005-02-18
4140-01-P
04-27781
Notice.
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive license worldwide to practice the invention embodied in of U.S. Patent 5,792,775, issued on August 11, 1998, entitled, ``4' and 4',4''-substituted-3-[alpha]-(diphenylmethoxy) tropane analogs as cocaine therapeutics' to Phase2 Discovery, having a place of business in the state of Ohio. The field of use may be limited to the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The United States of America is the assignee of the patent rights in this invention. This announcement is the first notice to grant an exclusive license to this technology.
Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before February 18, 2005, will be considered.
Patent licenses; non-exclusive, exclusive, or partially exclusive:
Phase2 Discovery,
ghoshpr@mail.nih.gov
Federal Register
Vol. 69, no. 243
Office of the Federal Register, National Archives and Records Administration
2004-12-20
continuing
daily
deposited
born digital
568 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2004-12-20
P0b002ee18097afb2
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr20de04
https://www.govinfo.gov/app/details/FR-2004-12-20
https://www.govinfo.gov/content/pkg/FR-2004-12-20/pdf/FR-2004-12-20.pdf
https://www.govinfo.gov/content/pkg/FR-2004-12-20/xml/FR-2004-12-20.xml
fdlp
75819
76372
DGPO
2010-09-23
2023-05-03
FR-2004-12-20
machine generated
eng
FR
FR-2004-12-20
69
243